21 February 2024
TruSpine Technologies
plc
("TruSpine" or the
"Company")
Notice of Adjourned
AGM
TruSpine Technologies Plc, the
medical device company focused on the spinal (vertebral)
stabilisation market, announces that notice of the Company's 2022
adjourned annual general meeting ("2022 AGM") has been sent to
shareholders today.
The 2022 AGM will be held at Regus,
Churchill Court 3, Crawley, RH10 9LU on 15 March 2024 at
13:00.
Certain of the original resolutions
have been withdrawn, these resolutions related to the Director's
authority to allot new ordinary shares in the Company and the
disapplication of pre-emption rights.
A copy of the notice of the 2022
AGM, along with the form of proxy, will be shortly available from
the Company's website http://truspine.org/
Enquiries:
|
TruSpine Technologies
Plc
|
Tel: +44 (0)20 7118 0852
|
|
Laurence Strauss, Chief Executive
Officer
|
|
|
|
|
|
Cairn Financial Advisers LLP
(AQSE Corporate Adviser)
|
Tel: +44
(0)20 7213 0880
|
|
Liam Murray / Ludovico
Lazzaretti
|
|
|
Peterhouse Capital Limited
(Broker & Financial Adviser)
|
Tel: +44 (0)20 7469 0930
|
|
Lucy Williams / Duncan
Vasey
|
|
|
Novus Communications (PR and
IR)
|
Tel: +44
(0)207 448 9839
|
|
Alan Green / Jacqueline
Briscoe
|
novuscomms@truspine.org
|
Caution regarding forward looking
statements
Certain statements in this
announcement, are, or may be deemed to be, forward looking
statements. Forward looking statements are identified by their use
of terms and phrases such as ''believe'', ''could'', "should"
''envisage'', ''estimate'', ''intend'', ''may'', ''plan'',
''potentially'', "expect", ''will'' or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements reflect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.